World Health Organization grants emergency use authorization to Johnson & Johnson vaccine

The World Health Organization on Friday granted emergency use authorization to the COVID-19 vaccine developed by Johnson & Johnson
and added it to its Covax program, which aims to ensure vaccine equity for lower income countries. “Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “But the hope offered by these tools will not materialize unless they are made available to all people in all countries.” The J&J vaccine has the advantage over others that it requires just one dose and does not have the same refrigeration requirements as the vaccines developed by Pfizer Inc.
and German partner BioNTech SE
or the one developed by Moderna Inc.
Those two shots require two doses weeks apart. Johnson & Johnson shares rose 0.3% Friday and are up 27% in the last 12 months.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *